About us
Reimagining health with regenerative medicine.
Cellise Therapeutics, in Selangor, Malaysia, is the global distribution partner for Cellular Regeneration Therapy (CRT). We work with Lamogen Laboratories in Queensland, Australia, to turn clinical research into treatment that doctors can use and patients can understand.
01 — Our view of health
Health is more than the absence of disease.
We see health as the presence of vitality, adaptability and longevity. Through translational research and biomedicine, we work on treatment that restores energy, strengthens wellbeing and extends health span: not only living longer, but staying well for longer.
That is why CRT works on the cells themselves rather than on the symptoms at the surface, and why we treat preventive care as seriously as treatment.
02 — What guides us
Three things we hold to.
-
i.
Science with purpose
We take advanced clinical research and turn it into practical treatment. What we offer has to be backed by evidence first.
-
ii.
Wellness through regenerative science
The goal is health that lasts: restored energy and stronger wellbeing, not a short spell of relief before the next round of treatment.
-
iii.
Working with clinicians
Regenerative medicine reaches further through doctors and organisations. We partner with them to move preventive care toward advanced biomedicine.
03 — Our partnership
Prepared by Lamogen, distributed by Cellise.
Lamogen Laboratories prepares the three CRT formulations, REDOX+, LIPON and LUMINA, in Queensland, Australia. Cellise Therapeutics distributes them and works with doctors on how the protocol is used.
Prepared by
TM
Lamogen Laboratories
Queensland, Australia.
Global distribution partner
Cellise Therapeutics
Selangor, Malaysia.
Chief Science Officer
Dr Kals Nathan
Clinical research scientist and regenerative medicine physician, Cellise Therapeutics.
Everything we put forward has to be scientifically credible, and built around the person receiving it.
Questions about CRT, for yourself or your practice?
Contact us →